Home Tags Diabetes: Type II

Tag: Diabetes: Type II

Men receiving 5α-reductase inhibitors have an increased risk for new-onset type 2 diabetes mellitus

Risk for T2DM Increased With Use of 5α-Reductase Inhibitors

Increased risk seen among men using dutasteride, finasteride for benign prostatic hyperplasia
A very low-carbohydrate

Low-Carb Breakfast May Improve All-Day Glucose Control in T2DM

In addition, high-fat, low-carb breakfast tied to less hunger later in the day
The U.S. Food and Drug Administration policy on added sugar labeling could be a cost-effective way of improving health

Added Sugar Labeling Could Reduce CVD, Diabetes Cases

Labeling would result in gain in quality-adjusted life-years and health care and societal cost savings
Canagliflozin is associated with a reduced risk for renal and cardiovascular events for patients with type 2 diabetes and kidney disease

Canagliflozin Seems Effective for Patients With T2DM, Kidney Disease

Reductions seen in risk for kidney failure, cardiovascular disease with canagliflozin versus placebo
The cardiovascular risks associated with type 2 diabetes mellitus are greater for patients diagnosed before age 40 years

Early T2DM Diagnosis Linked to Increased Cardiovascular Risk

Highest excess risk for mortality, CV mortality, heart failure, CHD seen for T2DM patients diagnosed before 40
There is a positive association between use of topical corticosteroids and incident type 2 diabetes

Topical Corticosteroids Associated With Higher Risk for Type 2 Diabetes

Dose-response relationship observed in large European cohort
Liquid meal replacements in weight loss diets lead to modest reductions in cardiometabolic risk factors for overweight and obese patients with type 2 diabetes

Liquid Meal Replacements Cut Cardiometabolic Risk Factors

Effects observed in overweight/obese patients with T2DM; certainty of evidence low to moderate
Patients with type 2 diabetes are frailer than participants without diabetes

Frailty May Up Fracture Risk in Patients With Type 2 Diabetes

Diabetes patients have higher frailty scores, which are tied to risk for incident fragility fractures
Individuals using statins may be at higher risk for hyperglycemia

Statins Tied to Insulin Resistance, Higher Serum Fasting Insulin

Ever use of statins associated with 38 percent increased risk for incident type 2 diabetes
Patients with type 2 diabetes are at increased risk for developing obstructive sleep apnea

Patients With Diabetes at Increased Risk for Sleep Apnea

In addition to known predictors of apnea, diabetes-related foot disease, insulin treatment up risk